The nutritional composition, antimicrobial properties, and health benefits of camel milk (CAM), cow milk (COM), and goat milk (GOM) have been extensively studied for their roles in managing diabetes and cardiovascular diseases (CVD). This review compares these milk types’ nutritional and therapeutic properties, emphasizing their applications in chronic disease management. CAM is rich in insulin-like proteins, vitamins, minerals, and bioactive compounds that benefit glycemic control and cardiovascular health. It also exhibits potent antioxidants, anti-inflammatory, and lipid-lowering effects, which are crucial for managing diabetes and reducing CVD risk factors. While COM and GOM provide essential nutrients, their impact on metabolic health differs. GOM is known for its digestibility and antihypertensive properties, whereas COM’s higher lactose content may be less suitable for diabetic patients. CAM’s unique nutritional profile offers distinct therapeutic benefits, particularly for diabetes and CVD management. Further research is needed to clarify its mechanisms of action and optimize its clinical application for chronic disease prevention and management.

The United Arab Emirates (UAE) is home to diverse indigenous medicinal plants traditionally used for centuries. This study systematically evaluates the pharmacological and nutritional potential of key medicinal plants, including Lawsonia inermis, Nigella sativa, Ziziphus spina-christi, Allium cepa, Allium sativum, Cymbopogon schoenanthus, Matricaria aurea, Phoenix dactylifera, Portulaca oleracea, Reichardia tingitana, Salvadora persica, Solanum lycopersicum, Trigonella foenum-graecum, Withania somnifera, and Ziziphus lotus. Comprehensive literature searches were conducted using PubMed, Scopus, and Web of Science to identify studies relevant to their nutritional and pharmacological uses. The findings highlight the therapeutic roles of these plants in managing global health challenges such as gastrointestinal diseases, and antimicrobial resistance through bioactive compounds like flavonoids, polyphenols, and antioxidants. Additionally, their contributions to nutrition, including essential vitamins and minerals, are emphasized for disease prevention and health promotion. While this research focuses on the UAE, the implications are globally relevant, as many of these plants are also found in traditional medicine across Asia, Africa, and Europe. Integrating these findings into global nutritional and healthcare systems offers potential solutions for pressing public health concerns, reduces reliance on synthetic pharmaceuticals, and promotes sustainable healthcare practices. This work is a valuable reference for researchers, healthcare professionals, and policymakers, bridging traditional knowledge and modern scientific applications globally.

This review explores the therapeutic potential of Allium cepa (onion) and Allium sativum (garlic), focusing specifically on their antidiabetic, cardioprotective, and antibacterial effects. These widely used medicinal plants are rich in bioactive compounds that contribute to their broad spectrum of pharmacological activities. Based on over two decades of scientific literature, this review synthesizes findings from more than 20 years of research to highlight the efficacy of these plant extracts. Rising chronic disease rates and antimicrobial resistance have renewed interest in plant-derived therapies; in the UAE context, Allium cepa and Allium sativum are promising candidates for integrative, sustainable interventions. This review further elucidates the mechanisms through which those bioactive constituents exert therapeutic effects, current extraction strategies, and challenges in enhancing formulations for functional health applications. Additionally, it addresses their role in sustainable healthcare practices due to their renewable nature and minimal environmental impact compared to synthetic pharmaceuticals.

This review critically explores the pharmacological potential of four traditionally significant medicinal plants—Phoenix dactylifera, Solanum lycopersicum, Withania somnifera, and Trigonella foenum-graecum—with a specific focus on their antidiabetic, cardioprotective, and antimicrobial properties. In light of the escalating global burden of chronic metabolic diseases and the alarming rise in antimicrobial resistance, there is an urgent demand for alternative, sustainable therapeutic strategies. Drawing upon both ethnopharmacological evidence and contemporary biomedical research, this study identifies and characterizes the key bioactive constituents responsible for the observed therapeutic effects. These phytochemicals include flavonoids, phenolic acids, alkaloids, and saponins, which modulate metabolic pathways, exert antioxidative and anti-inflammatory effects, and inhibit microbial proliferation. A systematic literature search was conducted across PubMed, Web of Science, and Scopus databases, covering peer-reviewed articles published between 2000 and 2025. Inclusion criteria emphasized both in vitro and in vivo experimental models to provide a holistic understanding of molecular mechanisms and biological efficacy. Importantly, this review does not propose these plant extracts as direct substitutes for clinically established therapies but rather as potential complementary agents or sources of novel compounds for future drug development. This integrative approach underscores the relevance of traditional medicinal knowledge in guiding the discovery of plant-based therapeutics. It highlights these species as promising candidates for innovative health interventions in the context of modern biomedicine and global public health.

This review highlights the significant therapeutic properties of four indigenous plants in the United Arab Emirates. These include Capparis spinosa L. (family: Capparaceae), commonly known as caper and locally referred to as Kabir; Citrullus colocynthis (L) Schrad. (family: Cucurbitaceae), known in English as bitter apple and locally as Alhanzal; Morus alba L. (family: Moraceae), referred to as white mulberry and locally named Firsad; and Rhazya stricta Decne. (family: Apocynaceae), commonly called harmal-e-shami and known locally as Alhi-rimi. These species are traditionally used for various ethnobotanical purposes and are important components of the region’s flora, such as managing diabetes and associated metabolic disorders. These plants contain diverse bioactive compounds with notable pharmacological activities. For example, caper exhibits antidiabetic effects through flavonoids such as quercetin and kaempferol, which enhance insulin sensitivity and lower blood glucose levels. Bitter apple is rich in cucurbitacins and alkaloids that lower glycated hemoglobin and support pancreatic β-cell function. White mulberry contains chlorogenic acid, rutin, and 1-deoxynojirimycin, which improve glucose uptake, inhibit α-glucosidase, and reduce oxidative stress. Harmal-e-shami exhibits variable antidiabetic activity, including dipeptidyl peptidase-IV inhibition and enhancement of glucagon-like peptide-1 secretion, which is influenced by the type and dosage of the extract. Despite these promising effects, challenges remain in standardization, phytochemical variability, and clinical validation. This review underscores the therapeutic potential of these plants and recommends further research for their integration into sustainable, plant-based diabetes management strategies.